Skip to content

Opening book details…

Can I read Resuscitative Endovascular Balloon Occlusion of the Aorta Associated with Improved Survival in Hemorrhagic Shock on EtoBox?

Resuscitative Endovascular Balloon Occlusion of the Aorta Associated with Improved Survival in Hemorrhagic Shock by Melike N. Harfouche; Marta J. Madurska; Noha Elansary; Hossam Abdou; Eric Lang; Joseph J. DuBose; Rishi Kundi; David V. Feliciano; Thomas M. Scalea; Jonathan J. Morrison is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Resuscitative Endovascular Balloon Occlusion of the Aorta Associated with Improved Survival in Hemorrhagic Shock about?

## Background Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is controversial as a hemorrhage control adjunct due to lack of data with a suitable control group. We aimed to determine outcomes of trauma patients in shock undergoing REBOA versus no-REBOA. ## Methods This single-center, retrospective, matched cohort study analyzed patients ≥16 years in hemorrhagic shock without cardiac arrest (2000–2019). REBOA (R; 2015–2019) patients were propensity matched 2:1 to historic (H; 2000–2012) and contemporary (C; 2013–2019) groups. In-hospital mortality and 30-day survival were analyzed using chi-squared and log rank testing, respectively. ## Results A total of 102,481 patients were included (R = 57, C = 88,545, H = 13,879). Propensity scores were assigned using age, race, mechanism, lowest systolic blood pressure, lowest Glasgow Coma Score (GCS), and body region Abbreviated Injury Scale scores to generate matched groups (R = 57, C = 114, H = 114). In-hospital mortality was significantly lower in the REBOA group (19.3%) compared to the contemporary (35.1%; p = 0.024) and historic (44.7%; p = 0.001) groups. 30-day survival was significantly higher in the REBOA versus no-

Who reads Resuscitative Endovascular Balloon Occlusion of the Aorta Associated with Improved Survival in Hemorrhagic Shock?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Melike N. Harfouche; Marta J. Madurska; Noha Elansary; Hossam Abdou; Eric Lang; Joseph J. DuBose; Rishi Kundi; David V. Feliciano; Thomas M. Scalea; Jonathan J. Morrison
Publisher
Public Library of Science (PLoS)
Published
2022
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Melike N. Harfouche; Marta J. Madurska; Noha Elansary; Hossam Abdou; Eric Lang; Joseph J. DuBose; Rishi Kundi; David V. Feliciano; Thomas M. Scalea; Jonathan J. Morrison

Browse all works by Melike N. Harfouche; Marta J. Madurska; Noha Elansary; Hossam Abdou; Eric Lang; Joseph J. DuBose; Rishi Kundi; David V. Feliciano; Thomas M. Scalea; Jonathan J. Morrison